Reata Pharmaceuticals (NASDAQ:RETA) Stock Rating Lowered by Barclays kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA) Downgraded by Stifel Nicolaus to Hold theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Jefferies Financial Group downgraded shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning, MarketBeat Ratings reports. The firm currently has $172.50 target price on the stock, up from their previous target price of $104.00. Other equities analysts also […]
Reata Pharmaceuticals (NASDAQ:RETA) Downgraded to Neutral at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA – Free Report) had its target price lifted by Robert W. Baird from $85.00 to $173.00 in a research note published on Monday morning, Marketbeat Ratings reports. Robert W. Baird currently has an outperform rating on the stock. RETA has been the topic of several other reports. StockNews.com initiated coverage on Reata […]